Neurocrine Biosciences (NBIX) Debt to Equity Ratio
Current and historical debt to equity ratio values for Neurocrine Biosciences (NBIX) over the last 10 years.
|Medical||Medical - Drug Manufacturing||$9.151B||$0.162B|
|Neurocrine Biosciences is a neuroscience-based company focused on the discovery and development of novel therapeutics for neuropsychiatric, neuroinflammatory and neurodegenerative diseases and disorders. The company's neuroscience, endocrine and immunology disciplines provide a unique biological understanding of the molecular interaction between central nervous, immune and endocrine systems for the development of therapeutic interventions for anxiety, depression, insomnia, stroke, malignant brain tumors, multiple sclerosis, obesity and diabetes.|